江苏晨牌药业集团股份有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
146
NMPA:146
Drug Approvals
Ambroxol Hydrochloride Oral Solution
- Product Name
- 盐酸氨溴索口服溶液
- Approval Number
- 国药准字H20253899
- Approval Date
- Apr 15, 2025
NMPA
Linezolid and Glucose Injection
- Product Name
- 利奈唑胺葡萄糖注射液
- Approval Number
- 国药准字H20243192
- Approval Date
- Feb 20, 2024
NMPA
Famciclovir Dispersible Tablets
- Product Name
- 泛昔洛韦分散片
- Approval Number
- 国药准字H20090129
- Approval Date
- Nov 22, 2023
NMPA
Pantoprazole Sodium Enteric-Coated Capsules
- Product Name
- 泮托拉唑钠肠溶胶囊
- Approval Number
- 国药准字H20093497
- Approval Date
- Nov 22, 2023
NMPA
Benzoylmetronidazole Dispersible Tablets
- Product Name
- 苯酰甲硝唑分散片
- Approval Number
- 国药准字H20080302
- Approval Date
- Sep 1, 2023
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 15
- Next
Clinical Trials
No trials found
News
No news found